The human squamous cervical carcinoma cell line, HOG-1, is responsive to steroid hormones

Int J Cancer. 1992 Sep 9;52(2):247-51. doi: 10.1002/ijc.2910520216.

Abstract

Growth of the human squamous cervical carcinoma cell line, HOG-I, was stimulated in response to oestradiol in serum-containing and chemically defined medium. The oestradiol-stimulated growth could be inhibited by 4-OH tamoxifen, progesterone and medroxyprogesterone acetate; the last 2 compounds also inhibited basal cell growth in serum-containing and chemically defined media. The data are consistent with the sensitivity of human squamous cervical cancer to sex-steroid hormones and suggest that endocrine therapies may be of benefit in this disease.

MeSH terms

  • Adult
  • Carcinoma, Squamous Cell / chemistry
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Cell Division / drug effects
  • Culture Media
  • Estradiol / pharmacology*
  • Female
  • Humans
  • Medroxyprogesterone / analogs & derivatives*
  • Medroxyprogesterone / pharmacology
  • Medroxyprogesterone Acetate
  • Tamoxifen / analogs & derivatives*
  • Tamoxifen / pharmacology*
  • Tumor Cells, Cultured
  • Uterine Cervical Neoplasms / chemistry
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / pathology

Substances

  • Culture Media
  • Tamoxifen
  • afimoxifene
  • Estradiol
  • Medroxyprogesterone Acetate
  • Medroxyprogesterone